Literature DB >> 29710120

A Histologic Study of the Circadian System in Parkinson Disease, Multiple System Atrophy, and Progressive Supranuclear Palsy.

Eduardo De Pablo-Fernández1,2, Robert Courtney1, Thomas T Warner1,2, Janice L Holton1.   

Abstract

Importance: Circadian dysfunction may be associated with the symptoms and neurodegeneration in Parkinson disease (PD), multiple system atrophy (MSA), and progressive supranuclear palsy (PSP), although the underlying neuroanatomical site of disruption and pathophysiological mechanisms are not fully understood. Objective: To perform a neuropathological analysis of disease-specific inclusions in the key structures of the circadian system in patients with PD, MSA, and PSP. Design, Setting, and Participants: This investigation was a brain bank case-control study assessing neuropathological inclusions in the suprachiasmatic nucleus (SCN) of the hypothalamus and pineal gland in healthy controls, PD (Lewy pathology), MSA (glial cytoplasmic inclusions), and PSP (tau inclusions). The study analyzed 12 healthy control, 28 PD, 11 MSA, and 21 PSP samples from consecutive brain donations (July 1, 2010, to June 30, 2016) to the Queen Square Brain Bank for Neurological Disorders and the Parkinson's UK Brain Bank, London, United Kingdom. Cases were excluded if neither SCN nor pineal tissue was available. Main Outcomes and Measures: Disease-specific neuropathological changes were graded using a standard semiquantitative scoring system (absent, mild, moderate, severe, or very severe) and compared between groups.
Results: Because of limited tissue availability, the following total samples were examined in a semiquantitative histologic analysis: 5 SCNs and 7 pineal glands in the control group (6 male; median age at death, 83.8 years; interquartile range [IQR], 78.2-88.0 years), 13 SCNs and 17 pineal glands in the PD group (22 male; median age at death, 78.8 years; IQR, 75.5-83.8 years), 5 SCNs and 6 pineal glands in the MSA group (7 male; median age at death, 69.5 years; IQR, 61.6-77.7 years), and 5 SCNs and 19 pineal glands in the PSP group (13 male; median age at death, 74.3 years; IQR, 69.7-81.1 years). No neuropathological changes were found in either the SCN or pineal gland in healthy controls or MSA cases. Nine PD cases had Lewy pathology in the SCN, and only 2 PD cases had Lewy pathology in the pineal gland. All PSP cases showed inclusions in the SCN, but no PSP cases had pathology in the pineal gland. Conclusions and Relevance: Disease-related neuropathological changes were found in the SCN but not in the pineal gland in PD and PSP, while both structures were preserved in MSA, reflecting different pathophysiological mechanisms that may have important therapeutic implications.

Entities:  

Mesh:

Year:  2018        PMID: 29710120      PMCID: PMC6142937          DOI: 10.1001/jamaneurol.2018.0640

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


  15 in total

1.  Nocturnal body core temperature falls in Parkinson's disease but not in Multiple-System Atrophy.

Authors:  G Pierangeli; F Provini; P Maltoni; G Barletta; M Contin; E Lugaresi; P Montagna; P Cortelli
Journal:  Mov Disord       Date:  2001-03       Impact factor: 10.338

2.  The core body temperature rhythm is altered in progressive supranuclear palsy.

Authors:  Keisuke Suzuki; Tomoyuki Miyamoto; Masayuki Miyamoto; Koichi Hirata
Journal:  Clin Auton Res       Date:  2009-02       Impact factor: 4.435

Review 3.  'The clocks that time us'--circadian rhythms in neurodegenerative disorders.

Authors:  Aleksandar Videnovic; Alpar S Lazar; Roger A Barker; Sebastiaan Overeem
Journal:  Nat Rev Neurol       Date:  2014-11-11       Impact factor: 42.937

4.  Circadian melatonin rhythm and excessive daytime sleepiness in Parkinson disease.

Authors:  Aleksandar Videnovic; Charleston Noble; Kathryn J Reid; Jie Peng; Fred W Turek; Angelica Marconi; Alfred W Rademaker; Tanya Simuni; Cindy Zadikoff; Phyllis C Zee
Journal:  JAMA Neurol       Date:  2014-04       Impact factor: 18.302

Review 5.  Neuroendocrine abnormalities in Parkinson's disease.

Authors:  Eduardo De Pablo-Fernández; David P Breen; Pierre M Bouloux; Roger A Barker; Thomas Foltynie; Thomas T Warner
Journal:  J Neurol Neurosurg Psychiatry       Date:  2016-10-31       Impact factor: 10.154

6.  Suprachiasmatic neuron numbers and rest-activity circadian rhythms in older humans.

Authors:  Joshua L Wang; Andrew S Lim; Wei-Yin Chiang; Wan-Hsin Hsieh; Men-Tzung Lo; Julie A Schneider; Aron S Buchman; David A Bennett; Kun Hu; Clifford B Saper
Journal:  Ann Neurol       Date:  2015-06-18       Impact factor: 10.422

7.  Differential involvement of hypothalamic vasopressin neurons in multiple system atrophy.

Authors:  Eduardo E Benarroch; Ann M Schmeichel; Paola Sandroni; Phillip A Low; Joseph E Parisi
Journal:  Brain       Date:  2006-05-02       Impact factor: 13.501

8.  Loss of nocturnal blood pressure fall in various extrapyramidal syndromes.

Authors:  Claudia Schmidt; Daniela Berg; Silke Prieur; Susann Junghanns; Katherine Schweitzer; Christoph Globas; Ludger Schöls; Heinz Reichmann; Tjalf Ziemssen
Journal:  Mov Disord       Date:  2009-10-30       Impact factor: 10.338

Review 9.  The central circadian timing system.

Authors:  Clifford B Saper
Journal:  Curr Opin Neurobiol       Date:  2013-05-22       Impact factor: 6.627

10.  Sleep and circadian rhythm regulation in early Parkinson disease.

Authors:  David P Breen; Romina Vuono; Upekshani Nawarathna; Kate Fisher; John M Shneerson; Akhilesh B Reddy; Roger A Barker
Journal:  JAMA Neurol       Date:  2014-05       Impact factor: 18.302

View more
  11 in total

Review 1.  Sleep-wake and circadian disturbances in Parkinson disease: a short clinical guide.

Authors:  Christian R Baumann
Journal:  J Neural Transm (Vienna)       Date:  2019-06-29       Impact factor: 3.575

Review 2.  Circadian rhythms in neurodegenerative disorders.

Authors:  Malik Nassan; Aleksandar Videnovic
Journal:  Nat Rev Neurol       Date:  2021-11-10       Impact factor: 42.937

Review 3.  Sleep Dysfunction in Movement Disorders: a Window to the Disease Biology.

Authors:  Jordan Standlee; Roneil Malkani
Journal:  Curr Neurol Neurosci Rep       Date:  2022-07-22       Impact factor: 6.030

4.  Subcortical Neuronal Correlates of Sleep in Neurodegenerative Diseases.

Authors:  Jun Y Oh; Christine M Walsh; Kamalini Ranasinghe; Mihovil Mladinov; Felipe L Pereira; Cathrine Petersen; Neus Falgàs; Leslie Yack; Tia Lamore; Rakin Nasar; Caroline Lew; Song Li; Thomas Metzler; Quentin Coppola; Natalie Pandher; Michael Le; Hilary W Heuer; Helmut Heinsen; Salvatore Spina; William W Seeley; Joel Kramer; Gil D Rabinovici; Adam L Boxer; Bruce L Miller; Keith Vossel; Thomas C Neylan; Lea T Grinberg
Journal:  JAMA Neurol       Date:  2022-05-01       Impact factor: 29.907

Review 5.  Defining circadian disruption in neurodegenerative disorders.

Authors:  Christopher S Colwell
Journal:  J Clin Invest       Date:  2021-10-01       Impact factor: 19.456

Review 6.  Sleep as a Therapeutic Target in the Aging Brain.

Authors:  Thierno M Bah; James Goodman; Jeffrey J Iliff
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

Review 7.  Sleep Issues in Parkinson's Disease and Their Management.

Authors:  José Rafael P Zuzuárregui; Emmanuel H During
Journal:  Neurotherapeutics       Date:  2020-10-07       Impact factor: 7.620

8.  Degeneration of human photosensitive retinal ganglion cells may explain sleep and circadian rhythms disorders in Parkinson's disease.

Authors:  Isabel Ortuño-Lizarán; Gema Esquiva; Thomas G Beach; Geidy E Serrano; Charles H Adler; Pedro Lax; Nicolás Cuenca
Journal:  Acta Neuropathol Commun       Date:  2018-09-10       Impact factor: 7.801

9.  Circadian sleep/wake-associated cells show dipeptide repeat protein aggregates in C9orf72-related ALS and FTLD cases.

Authors:  Lieselot Dedeene; Evelien Van Schoor; Rik Vandenberghe; Philip Van Damme; Koen Poesen; Dietmar Rudolf Thal
Journal:  Acta Neuropathol Commun       Date:  2019-12-02       Impact factor: 7.801

Review 10.  Impact of circadian and diurnal rhythms on cellular metabolic function and neurodegenerative diseases.

Authors:  S Kendall Smith; Erik S Musiek
Journal:  Int Rev Neurobiol       Date:  2020-07-10       Impact factor: 3.230

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.